Skip to Main Content

Paper Details

Emerging Genetic Therapy for Sickle Cell Disease.
Annu Rev Med
74
2019
-globin promoters, BCL11A, LRF, SCD, Sickle Cell Disease, ZBTB7A, fetal, fetal (-) globin gene, fetal hemoglobin, globin gene, hemoglobin, hereditary persistence of fetal hemoglobin, sickle cell disease
Author NameAffiliation
Stuart H OrkinHarvard Medical School
Stuart H OrkinHoward Hughes Medical Institute, Harvard Medical School
Daniel E BauerHarvard Medical School
  • 1 - 3

Datasets

Release 1.2